Twitter   Facebook   e-Newsletters   Podcsts   RSS Feeds   Share

158
DIOGENES® FDA Regulatory Updates

Last Loaded on Web: Wednesday, May 01, 2013

Last Update To Bluesheet: May 1, 2005

Bluesheet Contents     PDF version

File Description Dialog File Data DIALINDEX/OneSearch Categories Basic Index Rank
Sources Document Types Indexed Contact Additional Indexes Map
Tips Geographic Coverage Terms and Conditions Limit Predefined Format Options
Print Counterparts Special Features Sample Record Sort Rates


File Description [top]

DIOGENES FDA Regulatory Updates provides access to the Food and Drug Administration (FDA) regulatory information and is the database of choice for those researching the market status of FDA-approved pharmaceutials and medical devices. The database includes:

  • Premarket Notifications [510(k)s]. Every device ever declared substantially equivalent and therefore allowed onto the market under the Premarket Notification provisions of the Medical Device Amendments of 1976, including device name and classification, regulating advisory committee, sponsoring company, date of FDA decision, and 510(k) number.
  • Premarket Approvals (PMAs). All medical devices approved under the Premarket Approval provisions of the Medical Device Amendments of 1976. Individual entries include device name and manufacturer, date of approval, and regulating advisory committee.
  • Medical Device Reports (MDRs). Includes a record describing each adverse device experience submitted to the FDA from the beginning of the Medical Device Reporting plan in 1985.
  • New Drug List (NDL). A listing of every drug ever allowed onto the U.S. market since approval requirements began in 1938. Individual records include drug generic and trade names, Abbreviated New Drug Approval (ANDA) number, and data of approval. For affected drugs, date of market withdrawal, date of withdrawal of FDA permission to market Waxman-Hatch patent number, patent expiry, and patent exclusivity dates are also included.
  • The Enforcement Report. Covering back to 1984, each record of The Enforcement Report describes an instance of FDA-recorded field corrections and product recalls, indexed by company, product, recall number, extent of recall, and recall narrative. It describes pharmaceuticals, medical devices, biologics, foods, radiological products, veterinary medical products, and cosmetics.

    All material is acquired directly from the FDA and describes the approval and regulation of these products.



    Tips [top]

    USE FILE 158

    to monitor regulatory milestones for the pharmaceutical and medical device industry.

    EXPAND ON AC=, DT=, AND SO=

    to choose Advisory Committee, Device, or Source:

         E AC=ADVISORY COMMITTEE
         E DT=DEVICE
         E SO=510K

    ENTER SELECT STATEMENT AND RANK CO

    to see which companies are working in an area of interest:

         S (SO=510K AND (IMMUNO(W)ASSAY? OR IMMUNOASSAY?))/1996
         RANK CO



    Subject Coverage [top]



    Sources [top]

    DIOGENES FDA Regulatory Updates is made up of unpublished U.S. FDA documents acquired under the Freedom of Information Act, including: Advisory Committee minutes, drug and device approval information, regulatory letters, Establishment Inspection reports, Industry/FDA correspondence, and recall documentation.



    Print Counterparts [top]

    • None


Dialog File Data [top]

Dates Covered: 510(k)s and PMAs from 1976, MDRs from 1985, NDL from 1938, Reports from 1984
File Size: More than 2,315,140 records as of January 2012
Update Frequency: Closed


Document Types Indexed [top]

  • Government Documents
  • Press Releases


Geographic Coverage [top]

  • US Only


Geographic Restrictions [top]

  • None


Special Features [top]


DialIndex/OneSearch Categories [top]

ACRONYM CATEGORY NAME
BRANDNMS Brand Names
DRUGECON Pharmacoeconomics
MEDDEV Medical Devices
MEDENG Medical Engineering
PHARMIND Pharmaceutical Industry News
PHARMR Pharmacology + RINGDOC-Files
PHARMREG Pharmaceutical Regulation
REGS Regulations


Contact [top]

Diogenes is produced by the FOI Services, Inc. Questions concerning file content should be directed to:

FOI Services, Inc.
704 Quince Orchard Road
Suite 275
Gaithersburg, MD 20878

Telephone: +1 301-975-9400
Fax: +1 301-975-0702
E-Mail: diogenes@foiservices.com


Terms and Conditions [top]

DIOGENES is a registered trademark of FOI, Inc.

All bibliographic information and record identification in DIOGENES FDA Regulatory Updates is fully protected by copyright. Reproduction or photocopying even for internal use without the publisher's permission is prohibited. While every effort has been made to ensure that the information in the database is correct, DIOGENES FDA Regulatory Updates cannot accept any responsibility for errors or omissions.


Dialog Standard Terms & Conditions apply.


SAMPLE RECORD [top]

    DIALOG(R)File 158:DIOGENES(R) 
    (c) 2005 DIOGENES. All rts. reserv. 
     
  AA=  02530132   DIOGENES RECORD NUMBER: E0146083 
  /TI    NCS   Healthcare  of  Kentucky  CLASS  II  RECALL  11/30/04  &  12/01/04: 
     Metoclopramide Tablets, 5mg; 
    Folic Acid Tablets, 1mg. 
  /TN,/NA,NA=    DRUG NAME: Metoclopramide tablets, 5mg & folic acid tablets, 1mg. 
  /CO,CO=    COMPANY NAME: NCS Healthcare of Kentucky, Inc., Glasgow, KY. 
  SO=    SOURCE: FDA ENFORCEMENT REPORT 02/02/2005. 
  PD=    PUBLICATION  DATE:  November  30,  2004  ((20041130)December  01,  2004 
     ((20041201)) 
  RT=    RECORD TYPE: Fulltext 
  WD=,LT=    WORD COUNT:            143  (Short) 
  DT=    DOCUMENT TYPE:   DRUG  (DRG) 
  LA=    LANGUAGE: English 
  /TX    PRODUCT 
      a) Metoclopramide Tablets, USP, 5 mg tablets, Rx only, packaged in 30 and 31 
      count  grid  cards. NDC 
    0615-3546-39 and  NDC 0615-3546-31. Recall #D-107-5; 
      b)  Folic  Acid  Tablets, USP, 1 mg, Rx only, packaged in 30 and 31 count grid 
    cards. NDC 0615-0664-39 and 
    NDC 0615-0664-31. Recall # D-108-5. 
      CODE 
      a) Lot 3546-4009, exp. Date 10/31/05 and Lot 3546-4009, exp. Date 10/31/05; 
      b) Lot 0664-4010, exp. Date 10/31/05 and Lot 0664-4010, exp. Date 10/31/05. 
      RECALLING FIRM/MANUFACTURER 
      NCS  Healthcare  of Kentucky, Inc., Glasgow, KY, by facsimile on November 30, 
     2004 and by letter on 
    December l, 2004. Firm initiated recall is ongoing. 
      REASON  Mislabeling,  the outside grid card package is labeled as 
    Metoclopramide,5 mg, however, 
    individual blister packages contained within the 
    grid cards are labeled as, and contain, Folic Acid, 1 mg. 
      VOLUME OF PRODUCT IN COMMERCE 
      38,354 packages. 
      DISTRIBUTION 
      Nationwide. 
     
  FDA Citation:   
    DIALOG(R)File 158:DIOGENES(R) 
    (c) 2005 DIOGENES. All rts. reserv. 
     
  AA=  01881292   DIOGENES RECORD NUMBER: 733368 
  /TI   USI AUTOJECT INSULIN SYRINGE; FOI SUMMARY NOT AVAILABLE. 
  /DC    DEVICE CLASSIFICATION: (FMF) SYRINGE, PISTON. CLASS: 2. 21CFR: 880.586 
  SD=    SUBMISSION DATE: 19861205 
  EQ=    EQUIVALENCE CODE: (SE) SUBSTANTIALLY EQUIVALENT 
  /CO,CO=    COMPANY NAME: ULSTER SCIENTIFIC 
  /AC,AC=    ADVISORY  COMMITTEE:  GENERAL  HOSPITAL  AND  PERSONAL  USE  DEVICE PANEL 
      (DVGENPERS) 
  DN=    DEVICE/DRUG NO.: K864761 
  SO=    SOURCE: FDA 510(K) LIST (510K). LIST EDITION: January 2000 
  PD=,PY=    PUBLICATION DATE: December 16, 1986 (19861216) 
  RT=    RECORD TYPE: Citation 
  DT=    DOCUMENT TYPE:   DEVICE  (DEV)           $$$DC 
  LA=    LANGUAGE: English 


BASIC INDEX [top]

SEARCH
SUFFIX
DISPLAY
CODE
FIELD NAME
INDEXING
SELECT EXAMPLES
None None All Basic Index Fields Word S CIBA
/AC AC Advisory Committee1 Word S IMMUNOLOGY(W)DEVICE(W)PANEL/AC
/CO CO Company Name1 Word S ULSTER(W)SCIENTIFIC/CO
/DC DC Device Class Word S SYRINGE(W)PISTON?/DC
/ID ID Identifier2 Word
& Phrase
S INJECTABLE(W)DRUG?/ID
S INJECTABLE DRUG?/ID
/NA NA Drug Name1 Word S METOCLOPRAMIDE(W)TABLETS/NA
/TI TI Title Word S INSULIN(W)SYRINGE/TI
/TN TN Drug Brand Name1 Word S LOTREL/TN
/TX TX Text Word S FOLIC(W)ACID(W)TABLET?/TX
/XF XF All Basic Index Fields Except Full Text Word S CONTROLLED(W)RELEASE/XF

1 Searchable in the Basic Index and in the Additional Indexes.

2 Also /IF.


ADDITIONAL INDEXES [top]

SEARCH
PREFIX
DISPLAY
CODE
FIELD NAME
INDEXING
SELECT EXAMPLES
AA= AA DIOGENES Accession Number Phrase S AA=02530132
AC= AC Advisory Committee1 Phrase S AC="GENERAL HOSPITAL AND PERSONAL USE"?
None AZ DIALOG Accession Number
CO= CO Company Name1 Phrase S CO=ULSTER SCIENTIFIC?
DN= DN Drug/Device Number Phrase S DN=K864761
DT= DT Document Type Word S DT=DEVICE
EQ= EQ Equivalence Code Phrase S EQ=SE
FD= FD FDA Number Phrase S FD=D1411365-2000-00009
LA= LA Language Phrase S LA=ENGLISH
LT= LT Length of Text Phrase S LT=SHORT
S LT=LONG
ME= ME Market Exclusivity Reason Word
& Phrase
S ME=(ANTIGEN(W)REACTION)
S ME=(U-304)?
NA= NA Drug Name1 Phrase S NA=METOCLOPRAMIDE TABLET?
PD= PD Publication Date Phrase S PD=20041130
PE= PE Patent Expiration Date Phrase S PE=20051018?
PN= PN Patent Number Phrase S PN=US 4410520
PY= PY Publication Year Phrase S PY=2004
RT= RT= Record Type Phrase S RT=FULLTEXT
SD= SD Submission Date Phrase S SD=19861205
SO= SO Source Information Word S SO=(FDA(W)ENFORCEMENT(W)REPORT)
TN= TN Drug Brand Name1 Phrase S TN=LOTREL
UD= None Update Phrase S UD=9999
WD= WD Word Count Phrase S WD=143


LIMIT [top]

SUFFIX FIELD NAME EXAMPLES
/DEVICE Medical Device Record S S2/DEVICE
/DRUG Drug Record S S2/DRUG
/YYYY Publication Year S S3/2005


SORT [top]

SORTABLE FIELDS EXAMPLES
AC, CO, PD, PY, TI SORT S6/ALL/AC/PD,D
PRINT S3/5/1-24/CO


RANK [top]

RANK FIELDS EXAMPLES
All phrase- and numeric-indexed fields in the Additional Indexes can be ranked. Other RANK codes include: ID RANK ID


MAP [top]

MAP FIELDS EXAMPLES
PN MAP PN TEMP S2


USER-DEFINED FORMAT OPTIONS [top]

User-defined formats may be specified using the display codes indicated in the Search Options tables. TYPE S3/AC,TI,SO/1-5


PREDEFINED FORMAT OPTIONS [top]

NO.
DIALOGWEB
FORMAT
RECORD CONTENT
1 -- DIALOG Accession Number
2 -- Bibliographic Citation and Indexing
3 Medium Bibliographic Citation
4 -- Full Record with Tagged Fields
5 -- Full Record except Fulltext
6 Free Title and Word Count
7 -- Bibliographic Citation and Text
8 Short Title and Indexing
9 Full Full Record
K -- KWIC (Key Word In Context) displays a window of text; may be used alone or with other formats


DIRECT RECORD ACCESS [top]

FIELD NAME EXAMPLES
DIALOG Accession Number TYPE 02531330/5
DISPLAY 02530889/TI,TN
PRINT 02529638/3


Rates [top]

Rates For File: DIOGENES® FDA Regulatory Updates[158]
Cost per DialUnit:                $10.53
Cost per minute:                   $2.52
Rank Elements                      $0.00

Format    Types   Prints
     1    $0.00    $0.00
     2    $3.50    $3.50
     3    $3.50    $3.50
     4    $9.00    $9.00
     5    $9.00    $9.00
     6    $0.00    $0.00
     7    $9.00    $9.00
     8    $0.00    $0.00
     9    $9.00    $9.00
KWIC95    $1.50       NA
KWIC96    $1.50       NA

REDIST/COPY Multiplier Table:

      Range      Multiplier
        1-2       1.00
       3-25       1.50
     26-100       3.00
    101-200       4.00
    201-500       6.00
   501-1000       8.00
 1001 or more    10.00

ARCHIVE Multiplier Table:

      Range      Multiplier
       1-25       1.50
     26-200       3.00
    201-500       6.00
   501-1000       8.00
 1001 or more    10.00
[top]



All contents Copyright © Dialog, LLC. All rights reserved.
If you have any questions about, problems with, or corrections for our Web site,
please contact Customer Service for assistance.